Ausgabe 2/2018
Inhalt (19 Artikel)
Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury
Rhoderick M. Casis
Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
David Yeandle, Peter Rieckmann, Gavin Giovannoni, Nektaria Alexandri, Dawn Langdon
European and American Guidelines for Multiple Sclerosis Treatment
Angelo Ghezzi
Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
Charlotte Lawthom, Jukka Peltola, Rob McMurray, Emma Dodd, Vicente Villanueva
Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children
Yara Dadalti Fragoso, Tarso Adoni, Joseph B. Bidin Brooks, Alessandro Finkelsztejn, Paulo Diniz da Gama, Anderson K. Grzesiuk, Vanessa Daccach Marques, Monica Fiuza K. Parolin, Henry K. Sato, Daniel Lima Varela, Claudia Cristina F. Vasconcelos
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management
Kristen M. Ward, Leslie Citrome
A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment
Samuel D. Capouch, Martin R. Farlow, Jared R. Brosch
Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques
Maria Petracca, Monica Margoni, Giulia Bommarito, Matilde Inglese
A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS)
Freya Corfield, Dawn Langdon
Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated
U. Shivraj Sohur, David L. Gray, Sridhar Duvvuri, Yao Zhang, Kathleen Thayer, Gang Feng
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
Pamela Vo, Nicolas Paris, Aikaterini Bilitou, Tomas Valena, Juanzhi Fang, Christel Naujoks, Ann Cameron, Frederic de Reydet de Vulpillieres, Francois Cadiou
Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer Disease: An Observational Study. The Osaki-Tajiri Project
Kenichi Meguro, Satoshi Yamaguchi
Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
Lori Hendin Travis, Annette Okai, Steve Cavalier, Darren Stam, Lisa Farnett, Keith R. Edwards
Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers
Michelle Stewart, Shannon Shaffer, Brian Murphy, Jane Loftus, Jose Alvir, Michael Cicchetti, William R. Lenderking
Injection of Onabotulinum Toxin A into the Bilateral External Oblique Muscle Attenuated Camptocormia: A Prospective Open-Label Study in Six Patients with Parkinson’s Disease
Hiroyuki Todo, Hiroshi Yamasaki, Go Ogawa, Katsuya Nishida, Naonobu Futamura, Itaru Funakawa
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
Christine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, Saskia Bresch, Sylvia Benzaken, Romain Marignier, Barbara Seitz-Polski, Michel Ticchioni
Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
Giancarlo Comi, Ferdinando Nicoletti, Pier Luigi Canonico, Diego Centonze
Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
Pietro Annovazzi, Antonio Bertolotto, Vincenzo Brescia Morra, Claudio Gasperini, Enrico Montanari, Pierluigi Navarra, Francesco Patti, Maria Pia Sormani, Angelo Ghezzi
Acknowledgement to Authors, Referees, and Readers
Marwan N. Sabbagh, Antonio Bertolotto